La vendita allo scoperto per Capitol Series Trust The Nightview Fund NITE dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Capitol Series Trust The Nightview Fund NITE. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Capitol Series Trust The Nightview Fund NITE (ARCA:NITE), Report sulle vendite allo scoperto

Capitol Series Trust The Nightview Fund NITE

Niterra Co Ltd

NITERRA CO LTD UNSP/ADR by NITERRA CO LTD.

News

Camden Property Trust Reports Minor Damage From Hurricanes Helene And Milton, Will Provide Updates If Material Changes Occur

UMH Properties Reports Minimal Impact From Hurricane Milton, No Material Effect On Operations Or Financial Results

Insider Trades

ALVR

Octagon Capital Advisors Reports 9.7% Passive Stake In AlloVir

Looking into the current session, Permian Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) shares are trading at $14.52, after a 0.83% spike. Moreover, over the past month, the stock spiked by 7.64%, but in the past year, fell by 3.39%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1728677757_0.png" alt="Past Year Chart" />

<h3>Comparing Permian Resources P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Permian Resources has a lower P/E than the aggregate P/E of 18.07 of the Oil, Gas &amp; Consumable Fuels industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1728677757_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Permian Resources

The S&amp;P 500 and Dow Jones Industrial Average <a href="https://www.benzinga.com/news/earnings/24/10/41293799/s-p-500-dow-jones-hit-new-record-highs-as-financial-stocks-soar-on-upbeat-earnings">both achieved record highs</a> this week.
A strong kickoff to the third-quarter earnings season fueled both indexes, offsetting concerns from last <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41270761/september-inflation-hotter-than-expected-jobless-claims-spike-the-most-in-over-a-">month's unexpected inflation surge.</a>
JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), Bank of New York Mellon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) and BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) all exceeded analyst earnings forecasts Friday. This triggered a stock rally and propelled the financial <a href="https://www.benzinga.com/news/earnings/24/10/41293190/us-banks-top-q3-earnings-estimates-jpmorgan-delivers-robust-beat-financial-sector-stocks-hit-record">sector to new highs.</a>
In contrast, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) faced investor disappointment. The Austin, Texas-based car company is one of the worst performers within the S&amp;P 500 this week.
The much-anticipated "We, Robot" event on Thursday was partly to blame. The presentation failed to impress analysts and investors, alike. Critics said it was <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41295072/tesla-robotaxi-day-event-more-fanfare-than-substance-8-analysts-on-cybercab-optimus">more fanfare than substance</a>. 
While the company showcased its CyberCab and Optimus robot, key details about commercialization and timelines were lacking. The event sparked mixed reactions from investors, with concerns about whether Tesla can deliver on its ambitious autonomous vehicle promises.
As a result, the Elon Musk-led EV manufacturer saw its <a href="https://www.benzinga.com/markets/equities/24/10/41289653/tesla-stock-poised-to-pullback-to-1-month-low-whats-going-on">share price plunge Friday</a>. 
You might have missed…
<h3 class="wp-block-heading">Economic data disappoints</h3>
September inflation reports for both <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41270761/september-inflation-hotter-than-expected-jobless-claims-spike-the-most-in-over-a-">consumers</a> and <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41290382/producer-inflation-rises-more-than-expected-in-september-as-food-transportation-c">producers</a> come in higher than expected, while jobless claims posted the sharpest rise in over a year.
Despite the inflation uptick, interest rate expectations remained largely unchanged, with most traders and economists maintaining their outlook for <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41278012/feds-goolsbee-downplays-inflation-uptick-economists-hold-steady-on-november-rate-in">a November rate cut</a>. The unemployment spike was attributed to temporary factors, including Michigan auto layoffs and Hurricane Helene.
<h3 class="wp-block-heading">No Stimulus Measures In China</h3>
Chinese stocks saw their worst weekly performance of the year. The absence of expected stimulus measures from Chinese authorities weighed heavily on investor sentiment, despite a strong rally in recent weeks.
<h3 class="wp-block-heading">Mortgage Rates Surge</h3>
Mortgage rates saw a sharp reversal last week, jumping to 6.36% and leading to a 5.1% drop in homebuyer applications. The housing market awaits further rate cuts, but rising Treasury yields —driven by a resilient labor market — pose significant challenges to mortgage rate relief <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41249628/mortgage-rates-make-dramatic-u-turn-freezing-homebuyers-applications-fall-5-as-ma">in the near term.</a>
<h3 class="wp-block-heading">Google fights back</h3>
Alphabet Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google is challenging the Department of Justice&#8217;s efforts to break up its search dominance, labeling the proposed <a href="https://www.benzinga.com/markets/equities/24/10/41244481/google-cries-foul-as-doj-moves-to-break-up-search-giant-calls-recommendations-radical-as-antitru">antitrust remedies as radical.</a> 
The tech giant argues the DOJ's recommendations could dismantle its core business, impacting innovation and consumer choice.
Keep Reading:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41281645/18-stocks-to-buy-7-to-sell-this-earnings-season-goldman-sachs-calls-it-the-year-of-">18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It &#8216;The Year Of The Stock Picker&#8217;</a></li>
</ul>

Earnings

Equities

Econ #s

Economics

GOOGL

TSLA

Wall Street Marks New Record Highs On Strong Start To Earnings Season, Investors Downplay Inflation Surge, Tesla Disappoints: This Week In The Market

MAPS

WM Technology Got Notice Of Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Financing

AMCX

Millennium Management Reports 5.7% Passive Stake In AMC Networks

At September 30, 2024, Peabody has completed approximately $250 million of the anticipated $489 million of initial development capital to achieve longwall production in March 2026. With a $210 per metric ton benchmark price assumption, Centurion has an estimated net present value of $1.6 billion and a 25 percent internal rate of return.
"Peabody is committed to increasing shareholder value through a balanced approach of maximizing shareholder returns and developing Centurion," Mark Spurbeck, Peabody's Chief Financial Officer, said. "Centurion provides increased optionality to tightening metallurgical coal markets and will be a strategic asset in Peabody's global coal portfolio for decades."

Peabody Provides Update On Centurion Metallurgical Coal Mine Development; Integrated Mine Plan Complete With Estimated Net Present Value Of $1.6B; Average Annual Production Of 4.7M Tons At First Quartile Cost And Mine Life Of 25+ Years

At the recent <a href="https://www.benzinga.com/events/">Benzinga Cannabis Capital Conference</a> in Chicago (Oct. 8 and 9), Emily Paxhia, founding partner and managing partner of Poseidon Investment Management, shared her thoughts on one of the most pressing legal battles facing the cannabis industry. 
Speaking shortly after her panel, <a href="https://www.linkedin.com/feed/update/urn:li:activity:7249927868892286976">Paxhia discussed</a> a Supreme Court case that could have a transformative impact on how cannabis businesses operate within legal states, offering the industry a potential pathway to freedom from federal interference.
<h1 class="wp-block-heading">Supreme Court Battle</h1>
During the interview, Paxhia emphasized the importance of a Supreme Court case she is pursuing with David Boies, a renowned constitutional lawyer. This case could reshape the federal government's involvement in state-legal cannabis businesses. 
"I would love it if we could get more industry support around this case because it would define boundaries around our businesses that would let them run without the federal government&#8217;s overreach," said Paxhia. 
The case challenges a 2005 ruling on the Commerce Clause, which Paxhia believes is outdated. She explained the significance of the case: "All we're asking for is for the federal government to recognize that the industry exists within certain states, legal states, with programs, and that it would mean that the CSA [Controlled Substances Act] does not empower the DOJ [U.S. Department of Justice] to interfere with those businesses."
If successful, this case could lead to major changes for cannabis businesses. It could open up opportunities for banking access, insurance providers and credit card services — options that are currently denied to many cannabis operators. 
Paxhia pointed out, "It would create opportunities for us to have banking access, insurance providers, credit cards, all of the things that other businesses enjoy that we are simply deprived of."
<h1 class="wp-block-heading">The Burden of Federal Tax Code 280E</h1>
Paxhia also touched on the ongoing challenges that cannabis businesses face due to the federal tax code 280E, which prevents them from deducting ordinary business expenses. This has resulted in an effective tax rate of around 70% for many companies in the industry. 
She advised companies to remain financially cautious: "We are advising our companies to run lean and be very careful. We talk a lot about SG&amp;A containment and being prudent about the efficiencies of the operations."
Though there is hope that rescheduling cannabis could eliminate 280E, Paxhia noted that this is not an immediate solution. She highlighted that the case she is involved in could lead to retroactive refunds for cannabis businesses if the ruling is favorable: "This case would create a look back where you would be able to get a refund for prior years of 280E."
With a Supreme Court case on the horizon and the ongoing burden of 280E, Paxhia's message was clear: the cannabis industry needs to continue its fight for legal recognition while remaining financially prudent to navigate the existing challenges.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Don't miss your chance to be part of Cannabis Market Spotlight: California in Anaheim on Nov. 12. Whether you're looking to connect with industry leaders, explore investment opportunities, or gain the latest insights into California's cannabis market, this event has it all. <a href="https://cannabismarketspotlight.com/california/anaheim-november-12/">Secure your spot today!</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
Photo: Shutterstock

Cannabis

Government

Regulations

Legal

Events

Exclusives

Interview

Federal Overreach Vs. State Rights: Can Cannabis Businesses Gain Independence?

A2Z Cust2Mate Solutions Corp. (the "Company" or "A2Z") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZ#NASDAQ">AZ</a>), a global leader in innovative technology solutions, today announced that it has entered into a definitive securities purchase agreement with certain accredited investors to issue, in a registered direct offering, up to 642,860 common shares at a purchase price of US$2.80 per share. Subject to customary closing conditions, the transaction is expected to close on or around Tuesday, October 15, 2024. A2Z anticipates that the net proceeds from this offering, after deducting offering expenses, will be used for working capital and general corporate purposes. No placement agent was used or participated in the offering.

Offerings

A2Z Cust2Mate Solutions Announces Aggregate $1.8M Registered Direct Offering Of 642,860 Common Shares Priced At $2.80/Share, With No Warrants

FCPT

FCPT Announces Acquisition Of Tires Plus Property In Georgia For $2.1M Under Long-Term Triple Net Lease

China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) reported quarterly losses of $(2.04) per share. This is a 1233.33 percent decrease over earnings of $0.18 per share from the same period last year. The company reported $890.00 thousand in sales this quarter. This is a 34.56 percent decrease over sales of $1.36 million the same period last year.

CLEU

China Liberal Education H1 EPS $(2.04) Down From $0.18 YoY, Sales $890.00K Down From $1.36M YoY

<a href="https://x.com/IranIntl_En/status/1844812179826212963">https://x.com/IranIntl_En/status/1844812179826212963</a>
"Nearly all three branches of Iran's government - the judiciary, the legislature and the executive branch - have been hit by heavy cyberattacks, and their information stolen," said Firouzabadi, the ex-secretary of Iran's Supreme Council of Cyberspace, without explaining when those attacks happened.&nbsp;
"Our nuclear facilities have also been targeted by cyberattacks, as well as networks like fuel distribution, municipal networks, transportation networks, ports, and similar sectors. These are just part of a long list of various areas across the country that have been attacked."

Macro Economic Events

Global

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Iran International English Posts On X ""Nearly all three branches of Iran's government - the judiciary, the legislature and the executive branch - have been hit by heavy cyberattacks, and their information stolen," said Firouzabadi, the ex-secretary of Iran's Supreme Council of Cyberspace, without explaining when those attacks happened...."

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock&#39;s price. Do they really matter, though?
Let&#39;s take a look at what these Wall Street heavyweights have to say about TJX (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tjx#NYSE">TJX</a>) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
TJX currently has an average brokerage recommendation of 1.24, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 25 brokerage firms. An ABR of 1.24 approximates between Strong Buy and Buy.
Of the 25 recommendations that derive the current ABR, 22 are Strong Buy, representing 88% of all recommendations.
<h2>Brokerage Recommendation Trends for TJX</h2>
<img alt="Broker Rating Breakdown Chart for TJX" class="chart" src="https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/TJX_10112024.png" style="width:100%" title="" /> 
The ABR suggests buying TJX, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every &quot;Strong Sell&quot; recommendation, brokerage firms assign five &quot;Strong Buy&quot; recommendations.
In other words, their interests aren&#39;t always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock&#39;s price movement.
With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock&#39;s near -term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.
<h2>ABR Should Not Be Confused With Zacks Rank</h2>
In spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers&#39; vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.
There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.
<h2>Should You Invest in TJX?</h2>
Looking at the earnings estimate revisions for TJX, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $4.15.
Analysts&#39; steady views regarding the company&#39;s earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for TJX.
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for TJX.
<a href="https://www.zacks.com/stock/news/2349272/is-it-worth-investing-in-tjx-tjx-based-on-wall-street-s-bullish-views?cid=CS-BENZ-FT-fundamental_analysis|average_broker_rating-2349272">To read this article on Zacks.com click here.</a>

Large Cap

Analyst Ratings

Trading Ideas

Is It Worth Investing in TJX Based on Wall Street's Bullish Views?

VLDX

Velo3D Inc Commences Workforce Reduction Impacting 46 Employees Globally

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock&#39;s price. Do they really matter, though?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let&#39;s see what these Wall Street heavyweights think about ServiceNow (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/now#NYSE">NOW</a>).
ServiceNow currently has an average brokerage recommendation&nbsp;of 1.29, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 34 brokerage firms. An ABR of 1.29 approximates between Strong Buy and Buy.
Of the 34 recommendations that derive the current ABR, 29 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 85.3% and 5.9% of all recommendations.
<h2>Brokerage Recommendation Trends for NOW</h2>
<img alt="Broker Rating Breakdown Chart for NOW" class="chart" src="https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/NOW_10112024.png" style="width:100%" title="" /> 
While the ABR calls for buying ServiceNow, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every &quot;Strong Sell&quot; recommendation, brokerage firms assign five &quot;Strong Buy&quot; recommendations.
This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock&#39;s future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.
Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock&#39;s price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.
<h2>ABR Should Not Be Confused With Zacks Rank</h2>
Although both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company&#39;s changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
<h2>Is NOW a Good Investment?</h2>
Looking at the earnings estimate revisions for ServiceNow, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $13.75.
Analysts&#39; steady views regarding the company&#39;s earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for ServiceNow.
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for ServiceNow.
<a href="https://www.zacks.com/stock/news/2349270/is-servicenow-now-a-buy-as-wall-street-analysts-look-optimistic?cid=CS-BENZ-FT-fundamental_analysis|average_broker_rating-2349270">To read this article on Zacks.com click here.</a>

Tech

Is ServiceNow a Buy as Wall Street Analysts Look Optimistic?

Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) has outperformed the market over the past 5 years by 32.37% on an annualized basis producing an average annual return of 46.55%. Currently, Capricor Therapeutics has a market capitalization of $616.28 million. 
Buying $1000 In CAPR: If an investor had bought $1000 of CAPR stock 5 years ago, it would be worth $6,785.99 today based on a price of $17.44 for CAPR at the time of writing.
<h3>Capricor Therapeutics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728677024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPR

$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today

Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has outperformed the market over the past 5 years by 5.96% on an annualized basis producing an average annual return of 20.14%. Currently, Goldman Sachs Gr has a market capitalization of $163.24 billion. 
Buying $1000 In GS: If an investor had bought $1000 of GS stock 5 years ago, it would be worth $2,510.49 today based on a price of $516.92 for GS at the time of writing.
<h3>Goldman Sachs Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728677020_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today

Hingham Institution (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>) reported quarterly earnings of $1.44 per share. This is a 9.09 percent increase over earnings of $1.32 per share from the same period last year. The company reported $11.26 million in sales this quarter. This is a 4.28 percent decrease over sales of $11.76 million the same period last year.

Comments

Capitol Series Trust The Nightview Fund NITE

Vendite allo scoperto

Capitol Series Trust The Nightview Fund NITE (ARCA:NITE), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO